Boston Scientific Corp

RHUMBLINE ADVISERS BSX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,697,525

Value ($000)

257,209

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	257,209	0.2%	2,697,525	12/31/2025
2025 Q3	11/6/2025	266,168	0.2%	2,726,293	9/30/2025
2025 Q2	8/12/2025	294,048	0.3%	2,737,625	6/30/2025
2025 Q1	5/29/2025	282,105	0.3%	2,796,444	3/31/2025
2024 Q4	5/29/2025	244,865	0.2%	2,741,438	12/31/2024
2024 Q3	11/12/2024	239,236	0.2%	2,854,841	9/30/2024
2024 Q2	8/1/2024	227,905	0.2%	2,959,422	6/30/2024
2024 Q1	5/9/2024	203,476	0.2%	2,970,888	3/31/2024
2023 Q4	2/8/2024	170,903	0.2%	2,956,286	12/31/2023
2023 Q3	11/9/2023	155,636	0.2%	2,947,652	9/30/2023
2023 Q2	8/8/2023	158,133	0.2%	2,923,519	6/30/2023
2023 Q1	5/11/2023	145,485	0.2%	2,907,961	3/31/2023
2022 Q4	2/14/2023	135,348	0.2%	2,925,173	12/31/2022
2022 Q3	11/10/2022	105,754	0.2%	2,730,534	9/30/2022
2022 Q2	8/11/2022	99,281	0.1%	2,663,831	6/30/2022
2022 Q1	5/12/2022	113,605	0.1%	2,565,033	3/31/2022
2021 Q4	2/10/2022	105,703	0.1%	2,488,291	12/31/2021
2021 Q3	11/12/2021	107,206	0.1%	2,470,745	9/30/2021
2021 Q2	8/5/2021	109,059	0.1%	2,550,494	6/30/2021
2021 Q1	5/6/2021	103,382	0.1%	2,674,825	3/31/2021
2020 Q4	2/10/2021	102,760	0.1%	2,858,406	12/31/2020
2020 Q3	11/12/2020	107,027	0.2%	2,801,009	9/30/2020
2020 Q2	8/13/2020	98,664	0.2%	2,810,139	6/30/2020
2020 Q1	5/6/2020	89,542	0.2%	2,744,177	3/31/2020
2019 Q4	2/5/2020	120,205	0.2%	2,658,225	12/31/2019
2014 Q2	8/6/2014	23,586	0.1%	1,846,996	6/30/2014
2014 Q1	5/6/2014	25,572	0.1%	1,891,432	3/31/2014
2013 Q4	2/3/2014	23,500	0.1%	1,955,092	12/31/2013